LH:FSH Ratio in PCOS: What 2:1 Means and Why It Is Not Diagnostic

What does an LH:FSH ratio of 2:1 actually mean?

LH and FSH are both released by the pituitary gland in response to the same signal from the hypothalamus, and in a typical early-follicular-phase blood draw they sit close to a 1:1 ratio. In PCOS, faster and higher-amplitude pulses of gonadotropin-releasing hormone push the pituitary toward making more LH relative to FSH — a pattern that shows up as a ratio of 2:1 or higher on a single morning blood draw. The mechanism runs through reduced negative feedback from progesterone, since irregular ovulation means less progesterone is produced to slow the pulse generator down.

Note: PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, in May 2026, by a global consensus of more than 50 organisations. The gonadotropin pattern behind an elevated LH:FSH ratio is unchanged — only the name on the diagnosis is. This article uses PCOS, since that is still the term most readers search.

Why the ratio is not diagnostic

The 2023 international PCOS guideline does not list the LH:FSH ratio among the criteria used for a full PCOS diagnosis, and neither did the 2003 Rotterdam consensus that preceded it — read the current Rotterdam criteria in full for the three it does rely on: irregular ovulation, biochemical or clinical hyperandrogenism, and ovarian morphology. The reason is straightforward: in a study of 119 women with confirmed PCOS, an LH:FSH ratio above 2:1 was found in only 54 of them — 45.4%. A test that misses more than half the people who have the condition cannot anchor a diagnosis on its own, however useful it is as one supporting piece of evidence.

A separate analysis went further: a 2006 study concluded the LH:FSH ratio has little practical use in diagnosing PCOS at all, given how much it varies with body weight, insulin levels, cycle timing and the specific immunoassay used to measure it. A 2016 review called it “a forgotten test” for the same reason — still clinically informative in the right context, no longer load-bearing for the diagnosis itself.

Calculating your ratio

The calculation itself is simple division: LH (in IU/L) divided by FSH (in IU/L), from values drawn on the same blood sample. A result of 6 IU/L LH and 3 IU/L FSH gives a ratio of 2.0. Two things change the answer more than the arithmetic does: cycle timing and units. The ratio is only meaningful when both hormones are drawn in the early follicular phase — day 2 to day 5 of a cycle, if cycles are regular enough to count days from — since FSH rises later in the cycle and would understate the ratio if the draw happens after ovulation. And both values need to be reported in the same units (IU/L is standard) before you divide one by the other; mixing units from two different lab reports produces a meaningless number.

Reading your ratio by phenotype

Whether an elevated ratio shows up at all tracks closely with which PCOS phenotype you have, which is the main reason it lost its place as a stand-alone criterion. The Banaszewska 2003 study found the elevated ratio clustered in women with normal insulin levels, while most of the women with hyperinsulinemia and a higher body weight had a normal gonadotropin ratio despite otherwise meeting PCOS criteria. In practice, that means lean phenotypes are more likely to show a high LH:FSH ratio, and insulin-resistant phenotypes — where hyperinsulinemia suppresses the pituitary signal along with lowering SHBG — are more likely to show a normal one. A normal ratio in someone with clear insulin resistance is not evidence against PCOS; it is closer to the expected pattern.

What a high ratio is still useful for

None of this makes the ratio worthless — it is a supporting data point your clinician reads alongside the rest of your blood panel, not a discarded one. A markedly elevated ratio in someone with irregular cycles and clinical signs of excess androgens adds weight to a PCOS picture that ultrasound or AMH testing can then confirm. It is also a useful early flag in adolescents, where ovarian ultrasound criteria are harder to apply reliably. What it cannot do is stand in for the Rotterdam criteria, rule PCOS in in isolation, or rule PCOS out when it comes back normal.

Who this doesn’t work for

The ratio is uninterpretable in several common situations, and a value drawn in any of them should be disregarded rather than treated as diagnostic either way. It is meaningless on hormonal contraception, which suppresses both LH and FSH together. It shifts with cycle day, so a value from outside the early follicular phase — including any single draw in someone with cycles too irregular to date — cannot be compared against the ranges above. It behaves differently around perimenopause, when FSH rises independent of PCOS and can flatten or invert the ratio. And in women with significant obesity or marked insulin resistance, as the phenotype data above shows, the ratio is more likely to sit inside the normal range regardless of whether PCOS is present.